Overview
There has been a paradigm shift in the management of patients with advanced lung cancer with the discovery of immune checkpoints and the development of immunotherapies, Immune checkpoint inhibitor therapy presents unique challenges to healthcare professionals. The spectrum of toxicities is broad, and potentially involves every organ system. Evaluation and successful management of these unique adverse events requires a coordinated multidisciplinary team of specialists. In addition, patients may be living with toxicities for extended periods impacting psycho-social aspects of their lives. This webinar seeks to provide a framework to assess and manage these potential toxicities.
- Management of immune related pneumonitis in the lung cancer population: Kim Rohan, AOCN, ANP-BC
- Management of immune related skin toxicities: Andreas Charalambous, PhD, RN
- Overview of Management of immune related toxicities and principles of immunosuppression: Marianne Davies DNP, ACNP-BC, AOCNP
- Discussion/Q&A: Faculty
This live webinar is designed to meet the educational needs of healthcare professionals, who diagnose and treat patients with lung cancer, including:
- Nurses, Advanced Practice Nurses, Nurse Navigators, and Lung Cancer Nurse Specialists.
- Respiratory Therapists, Occupational Therapists, Physiotherapists
- Care Coordinators, Social Workers, Psycho-Oncology Professionals
- Practicing Medical Oncologists and Physician Assistants
- Allied Health Care Professionals: Pharmacists, Social Workers, and Care Coordinators
Demonstrate understanding of the mechanism of action of immune checkpoint inhibitors (ICPI) and associated immune mediated adverse events (imAEs)
- Recognize and evaluate associated immune mediated adverse events (imAEs)
- Construct management strategies for imAEs utilizing multidisciplinary practice guidelines
- Illustrate effective patient education and communication plans regarding treatment with ICPIs and implementation strategies for management of imAEs
Marianne Davies
DNP, ACNP-BC-AOCNP
Presentation: Overview of management of Immune related toxicities and principle of Immunosuppression
Dr. Andreas Charalambous
PhD, RN
Presentation: management of Immune-related skin toxicities.
Kim Rohan
AOCN,ANP-BC
Presentation: Management of Immune related pneumonitis in the lung cancer population.
For any inquiries, please contact meetings@iaslc.org.
This live webinar is designed to meet the educational needs of healthcare professionals, who diagnose and treat patients with lung cancer, including:
- Nurses, Advanced Practice Nurses, Nurse Navigators, and Lung Cancer Nurse Specialists.
- Respiratory Therapists, Occupational Therapists, Physiotherapists
- Care Coordinators, Social Workers, Psycho-Oncology Professionals
- Practicing Medical Oncologists and Physician Assistants
- Allied Health Care Professionals: Pharmacists, Social Workers, and Care Coordinators
Demonstrate understanding of the mechanism of action of immune checkpoint inhibitors (ICPI) and associated immune mediated adverse events (imAEs)
- Recognize and evaluate associated immune mediated adverse events (imAEs)
- Construct management strategies for imAEs utilizing multidisciplinary practice guidelines
- Illustrate effective patient education and communication plans regarding treatment with ICPIs and implementation strategies for management of imAEs
Marianne Davies
DNP, ACNP-BC-AOCNP
Presentation: Overview of management of Immune related toxicities and principle of Immunosuppression
Dr. Andreas Charalambous
PhD, RN
Presentation: management of Immune-related skin toxicities.
Kim Rohan
AOCN,ANP-BC
Presentation: Management of Immune related pneumonitis in the lung cancer population.
For any inquiries, please contact meetings@iaslc.org.